Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1982; 47(02): 114-115
DOI: 10.1055/s-0038-1657141
DOI: 10.1055/s-0038-1657141
Original Article
The Stability of Factor IX Concentrate During Storage
Further Information
Publication History
Received 02 December 1981
Accepted 25 January 1982
Publication Date:
13 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198202/lookinside/thumbnails/10-1055-s-0038-1657141-1.jpg)
Summary
A storage study of factor IX concentrate was performed on 35 randomly selected batches that had been prepared between 1976 and 1980. Vacuum stability, dissolution time, F IX procoagulant activity, NAPTT, and thrombin generation were measured immediately after the manufacturing process and compared in this study with the results obtained from the spare samples analysed in 1981. No significant changes during storage at cold room temperature for up to 5 years were established. The product can thus be considered to be stable for 5 years at + 4° C.
-
References
- 1 Brozović M, Kirkwood TBL, Robertson I. Study of a proposed international standard for blood coagulation Factor IX. Thromb Haemostas 1976; 35: 222-236
- 2 Suomela H, Myllylä G. A Factor IX-concentrate for the treatment of HaemofiliaB (In Finnish, abstract in English). Duodecim 1971; 87: 31-38
- 3 Suomela H, Myllylä G, Raaska E. Preparation and properties of a therapeutic Factor IX concentrate. Vox Sang 1977; 33: 37-50
- 4 Hardisty RM, Macpherson JC. A one-stage Factor VIII (anti-haemophilic globulin) assay and its use on venous and capillary plasma. Thrombos Diathes Haemorrh 1962; 7: 215-229
- 5 Kingdon HS, Lundblad RL, Veltkamp JJ, Aronson DL. Potentially thrombogenic materials in Factor IX concentrates. Thrombos Diathes Haemorrh 1975; 33: 617-631